Metabolism and Pharmacokinetics of Selective Serotonin Reuptake Inhibitors

被引：0

作者：

C. Lindsay DeVane

机构：

[1] Medical University of South Carolina,Department of Psychiatry and Behavioral Sciences

来源：

Cellular and Molecular Neurobiology | 1999年 / 19卷

关键词：

selective serotonin reuptake inhibitors; metabolism; pharmacokinetics; fluoxetine; fluvoxamine; paroxetine; sertraline; citalopram; cytochrome P450;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

1. Five drugs with the predominant pharmacologic effect of inhibiting the neuronal reuptake of serotonin are available worldwide for clinical use. This class of psychoactive drugs, known as selective serotonin reuptake inhibitors (SSRIs), is comprised of fluoxetine, sertraline, paroxetine, fluvoxamine, and citalopram.

引用

页码：443 / 466

页数：23

共 50 条

[21] A review of the safety of selective serotonin reuptake inhibitors during pregnancy
Goldstein, DJ
Sundell, K
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 1999, 14 (05) : 319 - 324
[22] Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose
Isbister, GK
Bowe, SJ
Dawson, A
Whyte, IM
JOURNAL OF TOXICOLOGY-CLINICAL TOXICOLOGY, 2004, 42 (03): : 277 - 285
[23] Selective serotonin-reuptake inhibitors in the treatment of premature ejaculation
Moreland, AJ
Makela, EH
ANNALS OF PHARMACOTHERAPY, 2005, 39 (7-8) : 1296 - 1301
[24] Clinical implications of selective serotonin reuptake inhibitors-selective serotonin norepinephrine reuptake inhibitors pharmacogenetics during pregnancy and lactation
Koren, Gideon
Ornoy, Asher
PHARMACOGENOMICS, 2018, 19 (14) : 1139 - 1145
[25] Drug Interactions of Clinical Significance with Selective Serotonin Reuptake Inhibitors
Philip B. Mitchell
Drug Safety, 1997, 17 : 390 - 406
[26] The pharmacogenomics of selective serotonin reuptake inhibitors
Garcia-Marin, Luis M.
Rabinowitz, Jill A.
Ceja, Zuriel
Alcauter, Sarael
Medina-Rivera, Alejandra
Renteria, Miguel E.
PHARMACOGENOMICS, 2022, 23 (10) : 597 - 607
[27] Mechanism of action of serotonin selective reuptake inhibitors - Serotonin receptors and pathways mediate therapeutic effects and side effects
Stahl, SM
JOURNAL OF AFFECTIVE DISORDERS, 1998, 51 (03) : 215 - 235
[28] SELECTIVE SEROTONIN REUPTAKE INHIBITORS - ADVERSE-EFFECTS, TOXICITY AND INTERACTIONS
MITCHELL, PB
ADVERSE DRUG REACTIONS AND TOXICOLOGICAL REVIEWS, 1994, 13 (03) : 121 - 144
[29] Role of Selective Serotonin Reuptake Inhibitors in the Treatment of Hypochondriasis: A Systematic Review
Prithviraj, Manoj
Mohanraj, Palani Selvam
Patel, Tejas K.
Das, Arani
CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (09)
[30] Treatment with Selective Serotonin Reuptake Inhibitors in the Third Trimester of PregnancyEffects on the Infant
Hedvig Nordeng
Olav Spigset
Drug Safety, 2005, 28 : 565 - 581

← 1 2 3 4 5 →